Smarter thinking about pharmaceutical marketing
Robb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma marketing approach can positively affect patient outcomes.
At a time when patients are often moving quicker than life science organisations, with their desire for information and participation in decisions about their well-being, companies are being forced to think differently about product launches and how marketing content can be most effectively produced and aligned to patient needs.
Patients have access to an overwhelming amount of health and wellness information. Pharma companies must cut through the clutter with the most accurate and timely messaging to help drive positive patient outcomes. This has required them to think differently about how marketing content can be most effectively produced and distributed to align with patient needs.
When pharmaceutical companies streamline their marketing production through successful ‘decoupling’, they can funnel the resulting savings towards funding more messaging, or directly into R&D. For marketers and their agencies-of-record, this outsourcing model frees up time for them to focus on the high-value strategic work that can really make a difference.
• Read the full article in pharmaphorum's Deep Dive digital magazine
